Pharmaceutical Cleanroom Consumables FAQ

Purchasing decisions need to account for more than the basic function of the product. Depending on the application, pharmaceutical teams may also need to consider:

• environmental classification
• sterility requirements
• particle and fiber performance
• residue
• compatibility with cleaning agents and disinfectants
• packaging and presentation
• transfer into the controlled environment
• documentation
• fit with established procedures and quality requirements

Not every wipe used in pharmaceutical manufacturing needs to be sterile.

Sterile wipes are generally evaluated when the environment, process, or SOP calls for a sterile input, particularly in aseptic or highly controlled applications. Nonsterile cleanroom wipes may remain appropriate for other cleaning tasks where sterility is not required.

The distinction should be based on the specific process rather than a generalized assumption that sterile automatically means more suitable.

These terms describe different characteristics, and they should not be treated as interchangeable.

A dry wipe allows chemistry to be added at the point of use and can provide flexibility where solution or saturation requirements vary.

A presaturated wipe is supplied with solution incorporated into the wipe, reducing the preparation required by the operator.

A sterile wipe addresses a sterility requirement. Its suitability still depends on substrate performance, presentation, chemistry compatibility, and the intended task.

The appropriate combination depends on what your procedure requires.

1. Where will the product be used? Define the classified or controlled area and the surface involved.
2. Does the procedure require sterility? If so, confirm that the product and supporting documentation align with that requirement.
3. How will the product enter and be staged in the controlled environment? Packaging and transfer requirements can influence suitability.
4. What chemistry will it encounter? Evaluate compatibility with the cleaning agent or disinfectant used in the procedure.
5. What contamination characteristics matter? Particle and fiber generation, residue, and other cleanliness requirements should reflect the process risk.
6. How will the operator use it? The size, construction, and format should support the physical cleaning task.

This approach keeps product selection connected to the actual aseptic workflow.

The answer depends on what your quality system and application require. Relevant information may include:

• product specifications
• lot-specific documentation
• sterility support
• applicable certificates
• particle or residue data
• endotoxin information
• other performance data needed to evaluate the product

Rather than collecting documentation simply because it is available, determine what evidence is required to support qualification, internal review, and audit readiness for the intended application.

The product should be evaluated in the context of your internal procedures, quality system, intended use, and applicable framework.

Avoid reducing the decision to a claim that a particular wipe or consumable is universally “compliant.”

A consumable is one component within a broader controlled process. The more useful question is whether its sterility status, cleanliness characteristics, packaging, chemistry compatibility, and supporting documentation are appropriate for the procedure in which it will be used.

Isolators and restricted-access areas can create unique cleaning challenges because of access constraints and procedural controls. Specialized tools or product formats may be needed to reach the intended surface while supporting the requirements of the cleaning procedure.

Evaluate whether the product allows the operator to reach the intended surface while maintaining the control required by the procedure. Small features or difficult-to-reach areas may call for swabs, while broader surfaces may be better addressed with wipes, mops, or other formats.

Swabs can be useful for precision cleaning, validation support, and areas that are difficult to reach with a wipe. Wipes generally provide more practical coverage for larger surfaces and routine removal of particles or residues.

In pharmaceutical settings, the choice should account for surface geometry, cleanliness requirements, and the exact process step being performed.

A disinfectant decision needs to account for both efficacy requirements and the operating environment.

Product selection should be assessed under the actual conditions established in the facility’s procedures.

• the materials and surfaces being treated
• cleaning frequency
• required contact time
• residue profile
• operator handling
• surface compatibility
• the defined disinfection protocol

They deserve consideration early, not after the substrate has already been selected.

In controlled pharmaceutical environments, product format and packaging can affect how a consumable is staged, transferred, stored, and presented to the operator.

When sterility or controlled transfer matters, those requirements should be incorporated into product evaluation from the beginning.

Berkshire offers evaluation samples for many products so teams can assess fit within their actual pharmaceutical process before standardizing or expanding use.

An evaluation can provide practical information about:

• material compatibility
• absorbency
• handling
• fit with the cleaning task
• performance under actual operating conditions

The trial should reflect the intended application as closely as possible.

Berkshire offers customized options that can include substrate or material choices, size, saturation level, and packaging specifications.

Where customization is being considered, start by defining the process problem that the standard format does not adequately solve. That keeps customization connected to a real operational or validation requirement.

For a controlled process, the least expensive product to purchase is not necessarily the least expensive product to use.

Total cost extends beyond the purchase price. Waste, rework, cleaning variability, and process interruptions can all affect the true cost of a consumable within a controlled process.

A more complete evaluation considers:

• product performance
• usability
• documentation support
• fit within the procedure
• consequences of material or process mismatch

That gives purchasing, operations, and quality teams a more useful basis for comparison than unit price alone.

Berkshire supports pharmaceutical customers with samples, technical guidance, product evaluation, and customized solutions.

The objective is not to match an application to the nearest catalog item. It is to understand the cleaning task, environment, chemistry, sterility, and documentation requirements first, then evaluate products that fit those requirements.